BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martí Coma-Cros E, Biosca A, Lantero E, Manca ML, Caddeo C, Gutiérrez L, Ramírez M, Borgheti-Cardoso LN, Manconi M, Fernàndez-Busquets X. Antimalarial Activity of Orally Administered Curcumin Incorporated in Eudragit®-Containing Liposomes. Int J Mol Sci 2018;19:E1361. [PMID: 29734652 DOI: 10.3390/ijms19051361] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Rajwar TK, Pradhan D, Halder J, Rai VK, Kar B, Ghosh G, Rath G. Opportunity in nanomedicine to counter the challenges of current drug delivery approaches used for the treatment of malaria: a review. J Drug Target 2023;:1-15. [PMID: 36604804 DOI: 10.1080/1061186X.2022.2164290] [Reference Citation Analysis]
2 Huang S, Zhai B, Fan Y, Sun J, Cheng J, Zou J, Zhang X, Shi Y, Guo D. Development of Paeonol Liposomes: Design, Optimization, in vitro and in vivo Evaluation. Int J Nanomedicine 2022;17:5027-46. [PMID: 36303804 DOI: 10.2147/IJN.S363135] [Reference Citation Analysis]
3 Zothantluanga JH, Zonunmawii, Das P, Sarma H, Umar AK. Nanotherapeutics of Phytoantioxidants for Parasitic Diseases and Neglected Tropical Diseases. Phytoantioxidants and Nanotherapeutics 2022. [DOI: 10.1002/9781119811794.ch16] [Reference Citation Analysis]
4 Daniyan MO, Fisusi FA, Adeoye OB. Neurotransmitters and molecular chaperones interactions in cerebral malaria: Is there a missing link? Front Mol Biosci 2022;9:965569. [DOI: 10.3389/fmolb.2022.965569] [Reference Citation Analysis]
5 Choi MJ, Woo MR, Choi HG, Jin SG. Effects of Polymers on the Drug Solubility and Dissolution Enhancement of Poorly Water-Soluble Rivaroxaban. Int J Mol Sci 2022;23:9491. [PMID: 36012748 DOI: 10.3390/ijms23169491] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Parekh P, Serra M, Allaw M, Perra M, Marongiu J, Tolle G, Pinna A, Casu MA, Manconi M, Caboni P, Manzoni OJJ, Morelli M. Characterization of Nasco grape pomace-loaded nutriosomes and their neuroprotective effects in the MPTP mouse model of Parkinson’s disease. Front Pharmacol 2022;13:935784. [DOI: 10.3389/fphar.2022.935784] [Reference Citation Analysis]
7 Perra M, Manca ML, Tuberoso CI, Caddeo C, Marongiu F, Peris JE, Orrù G, Ibba A, Fernàndez-busquets X, Fattouch S, Bacchetta G, Manconi M. A green and cost-effective approach for the efficient conversion of grape byproducts into innovative delivery systems tailored to ensure intestinal protection and gut microbiota fortification. Innovative Food Science & Emerging Technologies 2022;80:103103. [DOI: 10.1016/j.ifset.2022.103103] [Reference Citation Analysis]
8 Boonhok R, Sangkanu S, Phumjan S, Jongboonjua R, Sangnopparat N, Kwankaew P, Tedasen A, Lim CL, Pereira ML, Rahmatullah M, Wilairatana P, Wiart C, Dolma KG, Paul AK, Gupta M, Nissapatorn V. Curcumin effect on Acanthamoeba triangularis encystation under nutrient starvation. PeerJ 2022;10:e13657. [PMID: 35811814 DOI: 10.7717/peerj.13657] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Bezerra JN, Gomez MCV, Rolón M, Coronel C, Almeida-bezerra JW, Fidelis KR, Menezes SAD, Cruz RPD, Duarte AE, Ribeiro PRV, Brito ESD, Coutinho HDM, Morais-braga MFB, Bezerra CF. Chemical composition, Evaluation of Antiparasitary and Cytotoxic Activity of the essential oil of Psidium brownianum MART EX. DC. Biocatalysis and Agricultural Biotechnology 2022;39:102247. [DOI: 10.1016/j.bcab.2021.102247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Khairani S, Fauziah N, Wiraswati HL, Panigoro R, Setyowati EY, Berbudi A. The Potential use of a Curcumin-Piperine Combination as an Antimalarial Agent: A Systematic Review. J Trop Med 2021;2021:9135617. [PMID: 34671402 DOI: 10.1155/2021/9135617] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Patra S, Singh M, Wasnik K, Pareek D, Gupta PS, Mukherjee S, Paik P. Polymeric Nanoparticle Based Diagnosis and Nanomedicine for Treatment and Development of Vaccines for Cerebral Malaria: A Review on Recent Advancement. ACS Appl Bio Mater 2021;4:7342-65. [PMID: 35006689 DOI: 10.1021/acsabm.1c00635] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
12 da Silva de Barros AO, Portilho FL, Dos Santos Matos AP, Ricci-Junior E, Alencar LMR, Dos Santos CC, Paumgartten FJR, Iram SH, Mazier D, Franetich JF, Alexis F, Santos-Oliveira R. Preliminary studies on drug delivery of polymeric primaquine microparticles using the liver high uptake effect based on size of particles to improve malaria treatment. Mater Sci Eng C Mater Biol Appl 2021;128:112275. [PMID: 34474834 DOI: 10.1016/j.msec.2021.112275] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
13 Albalawi AE, Alanazi AD, Sharifi I, Ezzatkhah F. A Systematic Review of Curcumin and its Derivatives as Valuable Sources of Antileishmanial Agents. Acta Parasitol 2021;66:797-811. [PMID: 33770343 DOI: 10.1007/s11686-021-00351-1] [Reference Citation Analysis]
14 Abd-elsalam WH, Saber MM, Abouelatta SM. Trehalosomes: Colon targeting trehalose-based green nanocarriers for the maintenance of remission in inflammatory bowel diseases. European Journal of Pharmaceutics and Biopharmaceutics 2021;166:182-93. [DOI: 10.1016/j.ejpb.2021.06.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Memvanga PB, Nkanga CI. Liposomes for malaria management: the evolution from 1980 to 2020. Malar J 2021;20:327. [PMID: 34315484 DOI: 10.1186/s12936-021-03858-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Trigo-Gutierrez JK, Vega-Chacón Y, Soares AB, Mima EGO. Antimicrobial Activity of Curcumin in Nanoformulations: A Comprehensive Review. Int J Mol Sci 2021;22:7130. [PMID: 34281181 DOI: 10.3390/ijms22137130] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
17 Biosca A, Cabanach P, Abdulkarim M, Gumbleton M, Gómez-Canela C, Ramírez M, Bouzón-Arnáiz I, Avalos-Padilla Y, Borros S, Fernàndez-Busquets X. Zwitterionic self-assembled nanoparticles as carriers for Plasmodium targeting in malaria oral treatment. J Control Release 2021;331:364-75. [PMID: 33497747 DOI: 10.1016/j.jconrel.2021.01.028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
18 Tu X, Duan C, Wu S, Fu S, Ye J. Identification of plumbagin as an effective chemotherapeutic agent for treatment of Gyrodactylus infections. Aquaculture 2021;535:736372. [DOI: 10.1016/j.aquaculture.2021.736372] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
19 Jash A, Ubeyitogullari A, Rizvi SSH. Liposomes for oral delivery of protein and peptide-based therapeutics: challenges, formulation strategies, and advances. J Mater Chem B 2021;9:4773-92. [PMID: 34027542 DOI: 10.1039/d1tb00126d] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
20 Hikal WM, Bratovcic A, Baeshen RS, Tkachenko KG, Said-al Ahl HAH. Nanobiotechnology for the Detection and Control of Waterborne Parasites. OJE 2021;11:203-223. [DOI: 10.4236/oje.2021.113016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Wang N, Zhang Y, Liu H, Wang A, Ren T, Gou J, Zhang Y, Yin T, He H, Tang X. Toxicity Reduction and Efficacy Promotion of Doxorubicin in the Treatment of Breast Tumors Assisted by Enhanced Oral Absorption of Curcumin-Loaded Lipid–Polyester Mixed Nanoparticles. Mol Pharmaceutics 2020;17:4533-47. [DOI: 10.1021/acs.molpharmaceut.0c00718] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
22 Liu Y, Xie X, Chen H, Hou X, He Y, Shen J, Shi J, Feng N. Advances in next-generation lipid-polymer hybrid nanocarriers with emphasis on polymer-modified functional liposomes and cell-based-biomimetic nanocarriers for active ingredients and fractions from Chinese medicine delivery. Nanomedicine: Nanotechnology, Biology and Medicine 2020;29:102237. [DOI: 10.1016/j.nano.2020.102237] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
23 Timbe PPR, Motta ADS, Isaía HA, Brandelli A. Polymeric nanoparticles loaded with Baccharis dracunculifolia DC essential oil: Preparation, characterization, and antibacterial activity in milk. J Food Process Preserv 2020;44. [DOI: 10.1111/jfpp.14712] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
24 Deda DK, Iglesias BA, Alves E, Araki K, Garcia CRS. Porphyrin Derivative Nanoformulations for Therapy and Antiparasitic Agents. Molecules 2020;25:E2080. [PMID: 32365664 DOI: 10.3390/molecules25092080] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
25 Li W, He Y, Zhang R, Zheng G, Zhou D. The curcumin analog EF24 is a novel senolytic agent. Aging (Albany NY) 2019;11:771-82. [PMID: 30694217 DOI: 10.18632/aging.101787] [Cited by in Crossref: 68] [Cited by in F6Publishing: 70] [Article Influence: 22.7] [Reference Citation Analysis]
26 Kakkar V, Saini K, Saini M, Kumar M, Narula P, Duggal I. Comparison of Therapeutic Efficacy of Nanoformulations of Curcumin vs Tetrahydrocurcumin in Various Disorders. Nanoformulations in Human Health 2020. [DOI: 10.1007/978-3-030-41858-8_17] [Reference Citation Analysis]
27 Ma Z, Wang N, He H, Tang X. Pharmaceutical strategies of improving oral systemic bioavailability of curcumin for clinical application. Journal of Controlled Release 2019;316:359-80. [DOI: 10.1016/j.jconrel.2019.10.053] [Cited by in Crossref: 106] [Cited by in F6Publishing: 94] [Article Influence: 26.5] [Reference Citation Analysis]
28 Sakurai Y, Kato A, Hida Y, Hamada J, Maishi N, Hida K, Harashima H. Synergistic Enhancement of Cellular Uptake With CD44-Expressing Malignant Pleural Mesothelioma by Combining Cationic Liposome and Hyaluronic Acid-Lipid Conjugate. J Pharm Sci 2019;108:3218-24. [PMID: 31229434 DOI: 10.1016/j.xphs.2019.06.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
29 Kim SW, Cha MJ, Lee SK, Song BW, Jin X, Lee JM, Park JH, Lee JD. Curcumin Treatment in Combination with Glucose Restriction Inhibits Intracellular Alkalinization and Tumor Growth in Hepatoma Cells. Int J Mol Sci 2019;20:E2375. [PMID: 31091659 DOI: 10.3390/ijms20102375] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
30 Sun J, Wang J, Ma L, Jiang T, Li X, Guo Q, Li X, Sui Z. Determination and pharmacokinetic study of isothiouronium-modified pyrimidine-substituted curcumin analog (1G), a novel antitumor agent, in rat plasma by liquid chromatography-tandem mass spectrometry. Artif Cells Nanomed Biotechnol 2019;47:1505-12. [PMID: 30991858 DOI: 10.1080/21691401.2019.1602537] [Reference Citation Analysis]
31 Maghrebi S, Prestidge CA, Joyce P. An update on polymer-lipid hybrid systems for improving oral drug delivery. Expert Opin Drug Deliv 2019;16:507-24. [PMID: 30957577 DOI: 10.1080/17425247.2019.1605353] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
32 Raza M, Bharti H, Singal A, Nag A, Ghosh PC. Long circulatory liposomal maduramicin inhibits the growth of Plasmodium falciparum blood stages in culture and cures murine models of experimental malaria. Nanoscale 2018;10:13773-91. [PMID: 29995025 DOI: 10.1039/c8nr02442a] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
33 Manconi M, Manca ML, Escribano-Ferrer E, Coma-Cros EM, Biosca A, Lantero E, Fernàndez-Busquets X, Fadda AM, Caddeo C. Nanoformulation of curcumin-loaded eudragit-nutriosomes to counteract malaria infection by a dual strategy: Improving antioxidant intestinal activity and systemic efficacy. Int J Pharm 2019;556:82-8. [PMID: 30528634 DOI: 10.1016/j.ijpharm.2018.11.073] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]